The tumor-suppressive function of LKB1 is illustrated by studies performed with LKB1-deficient mesenchymal cells, where loss of LKB1 showed decreased TGF-β ligand production as well as deficient paracrine TGF-β signaling. Here, STK11 is linked to neoplasm.